Plague - News & Journal Articles

Education & Training

Suggested Reading New Items 2005

Risk of Person-to-Person Transmission of Pneumonic Plague
Clinical Infectious Disease, Volume 40, April 2005, 1166-72.

Epidemiologic Determinants for Modeling Pneumonic Plague Outbreaks
Emerging Infectious Disease, Volume 10, Number 4, April 2004, 608-14.

American Society for Microbiology
Biodefense Quarterly
Center for Infectious Disease Research & Policy (CIDRAP)
Clinical Infectious Diseases (CID)
Emerging Infectious Diseases (EID)
Journal of Clinical Microbiology
Journal of the American Medical Association (JAMA)
New England Journal of Medicine
World Health Organization (WHO)

  American Society for Microbiology

Yersina pestis?etiologic agent of plague.
Clin Microbiol Rev 1997;10(1):35-66, Perry RD, Fetherston JD. [Full text]

In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
Antimicrob Agents Chemother 1996;40(11):2646-7, Frean JA, Arntzen L, Capper T, et al. [Full text]

In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
Antimicrob Agents Chemother 1995;39(9):2153-4, Smith MD, Vinh DX, Nguyen TT, et al. [Full text]

  Biodefense Quarterly

A plague war on your city: observations from TOPOFF.
Biodefense Quarterly 2000;2(2), Inglesby T, Grossman R, O'Toole T. [Full text]

  Center for Infectious Disease Research & Policy (CIDRAP)

Vaccine Prevents Flea Borne Plague in Mice
March 25, 2004, CIDRAP

Plague, Current comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment and prophylaxis
December 17, 2002, CIDRAP/IDSA

Plague Resource List
December 17,2002, CIDRAP

Clinical Pathway
2002, CIDRAP

Single gene change enables plague bacterium to ride in fleas
May 2, 2002, CIDRAP

Plague genome suggests organism evolved from gut to blood pathogen
October 10, 2001, CIDRAP, Robert Roos

  Clinical Infectious Diseases (CID)

Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985-1999
CID, 2004, 38:663-669

Risks and prevention of nosocomial transmission of rare zoonotic diseases.
Clin Infect Dis 2001;32:446-56, Weber DJ, Rutala WA. [Full text]

Cases of cat-associated human plague in the Western US, 1977-1998.
Clin Infect Dis 2000;30(6):893-900, Gage KL, Dennis DT, Orloski KA, et al. [Full text]

  Emerging Infectious Diseases (EID)

Epidemiological Determinants for Modeling Pneumonic Plague Outbreaks
EID, April 2004, Vol. 10, No.4

Bioterrorism Related Anthrax
Emerging Infectious Diseases, October 2002, Vol 8, No 10;Entire Issue

Emerging Infectious Diseases: A Whole Issue on Anthrax.
EID Vol 8, No.10, October 2002

  Journal of Clinical Microbiology

Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.
J Clin Microbiol 2001;39(10):3649-55, Lindler LE, Fan W, Jahan N. [Full text]

Recent emergence of new variants of Yersinia pestis in Madagascar.
J Clin Microbiol 1997;35(11):2826-33, Guiyoule A, Rasoamanana B, Buchrieser C, et al. [Full text]

  Journal of the American Medical Association (JAMA)

Plague as a biological weapon: medical and public health management.
JAMA 2000;283(17):2281-90, Inglesby TV, Dennis DT, Henderson DA, et al, for the Working Group on Civilian Biodefense. [Full text]

Safety Precautions to Limit Exposure From Plague Infected-Infected Patients
JAMA, Vol. 284, No.13 October 4, 2000

The United States and Biological Warfare: Secrets From the Early Cold War and Korea
JAMA, Vol. 282, No.19 November 17, 1999

Large-Scale Quarantine Following Biological Terrorism in the United States
JAMA, Vol.286, No.21

  New England Journal of Medicine

Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.
N Engl J Med 1997;337(10):677-80, Galimand M, Guiyoule A, Gerbaud G, et al. [Full text]

  World Health Organization (WHO)

Plague manual 1997: epidemiology, distribution, surveillance, and control
WHO. [Full text]